WOLF GEOFFREY 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Dec 21, 2017
Insider Transaction Report
Form 4
WOLF GEOFFREY
Director10% Owner
Transactions
- Conversion
Warrants
2017-12-19−37,850→ 277,150 totalExercise: $15.00From: 2017-09-01Exp: 2017-12-31→ Common Stock (37,850 underlying) - Sale
Common Stock, $.001 par value per share
2017-12-13$29.61/sh−7,804$231,076→ 100,771 total - Award
Common Stock, $.001 par value per share
2017-12-19$15.00/sh+37,860$567,900→ 111,497 total - Sale
Common Stock, $.001 par value per share
2017-12-18$20.68/sh−27,134$561,131→ 73,637 total
Footnotes (2)
- [F1]This Form 4 is a late filing reporting the changes in beneficial ownership of the Reporting Person as of December 19, 2017. This Form 4 was required to be filed within two business days of 12/13/2017, the date the Reporting Person sold shares.
- [F2]These Warrants could only be exercised between the following dates: (i) the earliest date on which the price per Share has traded at or above US$ 30.00 for at least three trading days out of any ten (10) consecutive trading days; and (ii) the Expiration Date (December 31, 2017). These Warrants became exercisable on September 1, 2017.